wean off tirzepatide To keep pounds off, patients may need to continue taking weight loss drug, study suggests Why Some Insurers Want Patients

The medications ability to promote fat breakdown may help reduce liver fat accumulation over time

At week 72, the clinical data showed that 36.8% of patients receiving semaglutide achieved fibrosis improvement without worsening of NASH and 62.9% achieved NASH resolution without worsening of fibrosis, compared with 22.4% and 34.3%, respectively, in the placebo group (Sanyal et al., 2025)

Participants achieved average weight loss of approximately 14% over 64 weeks, while those who remained on treatment achieved average weight loss of approximately 16.6%

Gupta Plastic Surgery partners with a 503B compounding pharmacy because these facilities follow FDA-regulated Current Good Manufacturing Practice (CGMP) standards, helping ensure consistent quality, safety, and reliability for every medication produced

Uccellatore A, et al

doi: 10.1016/j.contraception.2008.11.009 13 BerensonABRahmanMBreitkopfCRBiLX